Matthew Bellman, PhD

Founder & Chief Technology Officer at MYOLYN

Matthew Bellman, PhD has worked in various roles in the fields of human motor control and robotics since 2010. In 2010, they were a PhD student and Teaching Assistant at the University of Florida, where they worked on human motor control in the Nonlinear Controls and Robotics group under Dr. Warren Dixon. Their dissertation was titled: "Control of Stationary Cycling Induced by Functional Electrical Stimulation: A Switched Systems Theory Approach". Matthew also worked as a Research Intern at the Institute for Human and Machine Cognition, where they were a control systems engineer on the Mina robotic exoskeleton and the FastRunner. In 2013, they founded MYOLYN and served as its Chief Technology Officer, leading the lean development of a functional electrical stimulation (FES) cycling system (MyoCycle) for people living with paralysis. Matthew also prepared a Class II medical device 510(k) application and achieved clearance in only 97 days.

Matthew Bellman, PhD obtained their Doctor of Philosophy (Ph.D.) in Mechanical Engineering - Dynamics, Systems, and Controls from the University of Florida in 2015. Prior to this, they obtained a Magna Cum Laude B.Sc. with a Minor in Biomechanics in Mechanical Engineering from the University of Florida in 2011. Additionally, they obtained a certification in Introduction to Risk Management for Medical Devices and ISO 14971:2019 from medicaldeviceHQ.com in February 2020.

Links

Previous companies

IHMC logo